BioGalen Pharmaceuticals

Atorvastatin Tablets

Cardio-Diabetic · Tablets · 10mg / 20mg / 40mg

WhatsApp Enquiry

Trade Information

Minimum Order Qty 1,000,000 tablets
Capacity 100 Million Tablets per month
Strength 10mg / 20mg / 40mg
Private Labelling Custom branding, artwork & market-specific labelling
Lead Time 45–60 days from order confirmation
Payment Terms LC at sight, TT (advance / against documents)
Shipping FOB / CIF to major international ports including Mombasa, Dar es Salaam, Lagos, Durban, Manila, Phnom Penh
Pharmacopoeia BP, USP, IP compliant

Packing Options

  • Blister (Alu-Alu / Alu-PVC)
  • Strip pack
  • Bottle pack (HDPE)
  • Hospital bulk pack
  • Custom packing as per buyer requirement

Regulatory & Quality

Registration Status Registered in multiple African, Asian, and CIS markets. Dossier available for new market registration.
Regulatory Dossiers CTD / ACTD format dossiers available for submission to national drug authorities.
Stability Data Zone IVa & IVb stability data available (tropical climate conditions, 30°C/65% RH & 30°C/75% RH)
WHO Prequalification WHO-GMP Certified

Product Details

Composition Atorvastatin Calcium
Dosage Form Tablets
Pack Size 10x10, 10x15 / Custom packing available
Storage Store below 30°C in a dry place, protected from light and moisture
Shelf Life 24 months from date of manufacture

Description

Atorvastatin is one of the most widely used statins for lowering cholesterol and reducing cardiovascular risk. It is listed on the WHO Model List of Essential Medicines.

BioGalen manufactures Atorvastatin in 10mg, 20mg, and 40mg tablets. As cardiovascular disease risk rises across African markets, demand for statins for cardiovascular prevention is growing, offering steady repeat-order demand that complements antihypertensive and antidiabetic lines in distributor portfolios.

Mechanism of Action

Atorvastatin is a statin that competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis in the liver. Reduced intracellular cholesterol prompts liver cells to increase LDL receptor expression, which clears more LDL cholesterol from the blood. The result is lower circulating LDL cholesterol and triglycerides, which reduces the risk of atherosclerotic cardiovascular events.

Indications

  • Primary hypercholesterolaemia and mixed dyslipidaemia
  • Reduction of cardiovascular event risk
  • Secondary prevention after cardiovascular events

Available Variants

  • Atorvastatin Tablets 10mg
  • Atorvastatin Tablets 20mg
  • Atorvastatin Tablets 40mg

Frequently Asked Questions

What is Atorvastatin used for?
Atorvastatin is a statin (HMG-CoA reductase inhibitor) used to lower LDL cholesterol and reduce the risk of cardiovascular events, addressing the lipid and cardiovascular-risk dimension of cardiometabolic disease.
What strengths of Atorvastatin does BioGalen manufacture?
BioGalen manufactures Atorvastatin in 10 mg, 20 mg, and 40 mg tablets, under WHO-GMP with CTD and ACTD dossiers available.
Does BioGalen supply Atorvastatin for chronic-disease portfolios?
Yes. BioGalen supplies Atorvastatin to importers, distributors, government tenders, and health programmes across Africa, complementing antihypertensive and antidiabetic lines, with flexible packaging and private labelling.

Interested in Atorvastatin Tablets?

Get competitive pricing for bulk orders, private labelling, and contract manufacturing.